Drug profile · INN
flunitrazepam
HYPNODORM
flunitrazepam (HYPNODORM) is a gaba-a receptor; anion channel positive allosteric modulator. Associated with Alphapharm Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — flunitrazepam
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
flunitrazepam (HYPNODORM) is a gaba-a receptor; anion channel positive allosteric modulator. Associated with Alphapharm Pty Ltd.
Key facts
INN flunitrazepam
Brand HYPNODORM
Mechanism GABA-A receptor; anion channel positive allosteric modulator
Target GABA-A receptor; anion channel
Originator Alphapharm Pty Ltd
Mechanism of action
GABA-A receptor; anion channel positive allosteric modulator
Primary target: GABA-A receptor; anion channel
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Related & competitor drugs
Frequently asked questions
What is flunitrazepam?
flunitrazepam (HYPNODORM) is a gaba-a receptor; anion channel positive allosteric modulator. Associated with Alphapharm Pty Ltd.
What is the brand name for flunitrazepam?
HYPNODORM is a marketed brand name for flunitrazepam. Check FDA Drugs@FDA for the current US label holder and prescribing information.